Rediscovering the indispensable role of FDG PET in kidney cancer imaging

N Hasani, F Farhadi, B Saboury, M Morris, C Beegle - 2022 - Soc Nuclear Med
2695 Introduction: This exhibit explores the utility of FDG PET in renal cell carcinoma
subtypes. Additionally, the use of FDG in Total Body PET imaging of renal cancer will also …

Progress of Total-Body PET technical developments and clinical applications: what has changed since the innovation?

N Hasani, B Saboury, M Morris, S Paravastu, F Farhadi - 2022 - Soc Nuclear Med
2727 Introduction: This exhibit explores the utility of FDG PET in renal cell carcinoma
subtypes. Additionally, the use of FDG in Total Body PET imaging of renal cancer will also …

[HTML][HTML] The place of FDG PET/CT in renal cell carcinoma: value and limitations

Y Liu - Frontiers in oncology, 2016 - frontiersin.org
Unlike for most other malignancies, application of FDG PET/CT is limited for renal cell
carcinoma (RCC), mainly due to physiological excretion of 18F-fluoro-2-deoxy-2-d-glucose …

PET/CT for the diagnostic assessment of patients with renal cancer

E Fiasconaro, F Caobelli, N Quartuccio… - Clinical and …, 2018 - Springer
Purpose We discuss the current role of PET/CT in all phases of disease in RCC, potential
advancements in the diagnostic and prognostic work up, including future perspectives …

PET and PET/CT in kidney cancer

C Schiepers - Imaging of Kidney Cancer, 2006 - Springer
6.5 Conclusion Renal cell carcinoma comprises about 3% of all malignancies. FDG has a
modest affinity for RCC related to a lower expression of GLUT-1 than other cancers …

PET/Computed Tomography Transformation of Oncology: Kidney and Urinary Tract Cancers

JD Oldan, JA Schroeder, J Hoffman-Censits… - PET clinics, 2024 - pet.theclinics.com
Renal cell carcinoma (RCC) and urothelial carcinoma (UC) represent the third and second
most common genitourinary malignancies, trailing prostate cancer. 1 Both types of tumors …

[CITATION][C] Efficiency of [18F] FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT.

FF Marshall - The Journal of Urology, 2005 - europepmc.org
Efficiency of [18F]FDG PET in characterising renal cancer and detecting distant metastases: a
comparison with CT. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …

[HTML][HTML] Meta-analysis of the diagnostic performance of [18F] FDG-PET and PET/CT in renal cell carcinoma

HY Wang, HJ Ding, JH Chen, CH Chao, YY Lu… - Cancer …, 2012 - ncbi.nlm.nih.gov
Objectives: Positron emission tomography (PET) using fluorodeoxyglucose (FDG) is useful
for restaging renal cell carcinoma (RCC) and detecting metastatic diseases but is less …

[HTML][HTML] Is the value of FDG PET/CT in evaluating renal metastasis underestimated? A case report and review of the literature

M Aras, F Dede, T Önes, S İnanır, TY Erdil… - Molecular imaging …, 2013 - ncbi.nlm.nih.gov
Contrast-enhanced CT or MRI are used as a gold standard imaging modalities in the
detection and characterization of renal masses. On the other hand, the role of FDG PET/CT …

FDG in urologic malignancies

PF Hĝilund-Carlsen, MH Poulsen, H Petersen… - PET clinics, 2014 - pet.theclinics.com
In comparison with multiple other applications, positron emission tomography (PET) and
PET/computed tomography (PET/CT) imaging with 18F-fluorodeoxy-glucose (FDG) has …